[1] Ridker, Paul M., et al. "Antiinflammatory therapy with canakinumab for atherosclerotic disease." New England journal of medicine 377.12 (2017): 1119-1131.
[2] Fotheringham, James, et al. "The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients." Kidney international 88.3 (2015): 569-575.
[3] Ocak, Gurbey, et al. "Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis." JAMA network open 5.4 (2022): e227624-e227624.
[4] Fu, Edouard L., et al. "Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study." bmj 375 (2021).
[5] Braunisch, Matthias C., et al. "Cardiovascular mortality can be predicted by heart rate turbulence in hemodialysis patients." Frontiers in physiology 11 (2020): 77.
